| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibiotic treatment of urinary tract infection and its impact on the gut microbiota
|
van Nieuwkoop, Cees
|
|
|
22 |
3 |
p. 307-309
|
artikel
|
| 2 |
Assessment of experimental malaria vaccine induced protection in pre-exposed populations
|
Daubenberger, Claudia
|
|
|
22 |
3 |
p. 305-307
|
artikel
|
| 3 |
Cheryl Cohen—promoting evidence-based health policy
|
Kazi, Farooq
|
|
|
22 |
3 |
p. 325
|
artikel
|
| 4 |
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|
Wang, Minggui
|
|
|
22 |
3 |
p. 401-412
|
artikel
|
| 5 |
Compromised periodontal status could increase mortality for patients with COVID-19
|
Gupta, Shipra
|
|
|
22 |
3 |
p. 314
|
artikel
|
| 6 |
Concerts and COVID: can the beat go on?
|
Schlagenhauf, Patricia
|
|
|
22 |
3 |
p. 299-301
|
artikel
|
| 7 |
Correction to Lancet Infect Dis 2022; published online Jan 25. https://doi.org/10.1016/S1473-3099(21)00586-7
|
|
|
|
22 |
3 |
p. e73
|
artikel
|
| 8 |
COVID-19 kick-starts a new era for clinical trials and pandemic preparedness in Europe
|
Szepessy, Edit
|
|
|
22 |
3 |
p. 315-316
|
artikel
|
| 9 |
COVID-19 kick-starts a new era for clinical trials and pandemic preparedness in Europe
|
Depoortere, Evelyn
|
|
|
22 |
3 |
p. 315
|
artikel
|
| 10 |
COVID-19 vaccine inequity, dependency, and production capability in low-income and middle-income countries: the case of Bangladesh
|
Mahmud-Al-Rafat, Abdullah
|
|
|
22 |
3 |
p. 310-312
|
artikel
|
| 11 |
Defining post-COVID condition
|
Villar, Juan Carlos
|
|
|
22 |
3 |
p. 316-317
|
artikel
|
| 12 |
Education services in crisis due to COVID-19
|
Burki, Talha
|
|
|
22 |
3 |
p. 321-322
|
artikel
|
| 13 |
Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study
|
Desai, Devashish
|
|
|
22 |
3 |
p. 349-356
|
artikel
|
| 14 |
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
|
Kremsner, Peter G
|
|
|
22 |
3 |
p. 329-340
|
artikel
|
| 15 |
Efficacy, immunogenicity, and safety of a quadrivalent HPV vaccine in men: results of an open-label, long-term extension of a randomised, placebo-controlled, phase 3 trial
|
Goldstone, Stephen E
|
|
|
22 |
3 |
p. 413-425
|
artikel
|
| 16 |
Elimination of meningitis—are we there yet?
|
Marshall, Helen
|
|
|
22 |
3 |
p. 327
|
artikel
|
| 17 |
Facial Balamuthia mandrillaris infection with neurological involvement in an immunocompetent child
|
Zhang, Zhen
|
|
|
22 |
3 |
p. e93-e100
|
artikel
|
| 18 |
Global emergence of SARS-CoV-2 variants: new foresight needed for improved vaccine efficacy
|
Yadav, Pragya D
|
|
|
22 |
3 |
p. 298-299
|
artikel
|
| 19 |
Hunger as a barrier for HIV treatment
|
Cooper, Bethany
|
|
|
22 |
3 |
p. 328
|
artikel
|
| 20 |
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method
|
Nasa, Prashant
|
|
|
22 |
3 |
p. e74-e87
|
artikel
|
| 21 |
Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study
|
Haas, Eric J
|
|
|
22 |
3 |
p. 357-366
|
artikel
|
| 22 |
Infectious disease surveillance update
|
Zwizwai, Ruth
|
|
|
22 |
3 |
p. 322
|
artikel
|
| 23 |
Khorshed Pavri
|
Bagcchi, Sanjeet
|
|
|
22 |
3 |
p. 324
|
artikel
|
| 24 |
Mother-to-child transmission of HIV in Botswana
|
Bagcchi, Sanjeet
|
|
|
22 |
3 |
p. 319
|
artikel
|
| 25 |
Ocular toxocariasis presenting as leukocoria
|
Xie, Yue
|
|
|
22 |
3 |
p. 426
|
artikel
|
| 26 |
Peer review at The Lancet Infectious Diseases
|
McConnell, John
|
|
|
22 |
3 |
p. 313
|
artikel
|
| 27 |
Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial
|
Delaugerre, Constance
|
|
|
22 |
3 |
p. 341-348
|
artikel
|
| 28 |
Primaquine and the power of adherence in radical cure
|
Grobusch, Martin P
|
|
|
22 |
3 |
p. 304-305
|
artikel
|
| 29 |
Rapid COVID-19 vaccine rollout: immense success but challenges ahead
|
Sandmann, Frank G
|
|
|
22 |
3 |
p. 302-304
|
artikel
|
| 30 |
Regional differences in carbapenem-resistant Klebsiella pneumoniae
|
Wyres, Kelly
|
|
|
22 |
3 |
p. 309-310
|
artikel
|
| 31 |
Research in brief
|
Devi, Sharmila
|
|
|
22 |
3 |
p. 323
|
artikel
|
| 32 |
Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial
|
Sissoko, Mahamadou S
|
|
|
22 |
3 |
p. 377-389
|
artikel
|
| 33 |
SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines
|
Thiruvengadam, Ramachandran
|
|
|
22 |
3 |
p. 301-302
|
artikel
|
| 34 |
Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
|
Poespoprodjo, Jeanne Rini
|
|
|
22 |
3 |
p. 367-376
|
artikel
|
| 35 |
Thank you to The Lancet Infectious Diseases clinical and statistical peer reviewers in 2021
|
|
|
|
22 |
3 |
p. e66-e72
|
artikel
|
| 36 |
The clinical and microbiological efficacy of temocillin versus cefotaxime in adults with febrile urinary tract infection, and its effects on the intestinal microbiota: a randomised multicentre clinical trial in Sweden
|
Edlund, Charlotta
|
|
|
22 |
3 |
p. 390-400
|
artikel
|
| 37 |
The importance of understanding the infectious microenvironment
|
Bjarnsholt, Thomas
|
|
|
22 |
3 |
p. e88-e92
|
artikel
|
| 38 |
Transitioning to endemicity with COVID-19 research
|
The Lancet Infectious Diseases,
|
|
|
22 |
3 |
p. 297
|
artikel
|
| 39 |
Updates in pre-exposure prophylaxis for HIV
|
Mushtaq, Ammara
|
|
|
22 |
3 |
p. 320
|
artikel
|
| 40 |
Wolfgang Preiser—co-discoverer of SARS-CoV-2 variants
|
Kirby, Tony
|
|
|
22 |
3 |
p. 326
|
artikel
|
| 41 |
Worrying lack of funding for tuberculosis
|
Venkatesan, Priya
|
|
|
22 |
3 |
p. 318
|
artikel
|
Tijdschrift beschrijving